It’s World Prematurity Day — Time for Change

This post is sponsored by Cervilenz Inc.12.9 million babies are born too soon every year around the world, and 1 million of those babies die. The United States has the second-highest rate of prematurity in the world. Here, 1 of 8 babies is born prematurely, and these early deliveries are the leading cause of infant [...]

[Read more of this report]


Giving thanks: Advances in the fight against prematurity

This post is sponsored by Cervilenz Inc.November is a time for thanks. Every day, I am thankful for my husband, Jim, and our three healthy children– Emmett, Riley, and Allie. But, this time of year is a mixed blessing for me.November is Prematurity Awareness Month. Every minute of every day, a baby is born prematurely. [...]

[Read more of this report]


Women’s health devicemaker Cervilenz ups series A to $8.35M

Women’s health medical device company Cervilenz has increased its series A round of investment to $8.35 million, thanks to a recent tranche of funding from existing investors.Cleveland-area Cervilenz plans to use the funding to continue commercialization of its device, which provides a means of accurately and inexpensively measuring a pregnant woman’s cervix. A short cervix [...]

[Read more of this report]


MedCity News on ONN: A new innovative medical device for preterm birth

var page_count = “off”; if (typeof OAS_rdl == “undefined”) {document.write(“”); page_count = “on”;}var MMI_ClickURL = “”; var OAS_searchterms = “”;var OAS_taxonomy =”muid=0″;var MMI_RNS = (new String(Math.random())).substring(2, 11);var MMI_URL=”http://msite.martiniadnetwork.com/index/?pid=12005806154e90a4e91c116&sid=2048469434eb2fbee11a56&loc=”+ encodeURIComponent(window.location.toString()) + “&rnd=” + MMI_RNS;MMI_ClickURL += ((MMI_ClickURL.split(“/”).length – 1) % 2 )? “/”: “”;if (document.referrer [...]

[Read more of this report]


Progesterone drug approval could open new market for device firm CerviLenz

Pending regulatory approval of a progesterone drug could open up a new, lucrative market in helping prevent premature births for medical device maker CerviLenz.The drug, Prochieve 8%, is a gel that was associated in a Phase 3 clinical trial with a 45 percent reduction in preterm births in pregnant women with a short cervix, and [...]

[Read more of this report]


Device maker CerviLenz hires first financial, operating chief

Medical device startup CerviLenz Inc. has appointed its first chief financial/operating officer: Federica “Freddi” O’Brien, a certified public accountant who spent the last decade working with bioscience companies.“I have 30 years of experience working with middle-market, development-stage companies, as well as big pharma companies,” O’Brien said. “I had been tracking CerviLenz since I heard about [...]

[Read more of this report]


MedCity News on WKYC-TV: 3 Cleveland medical devices

MedCity News President Chris Seper appeared on air of content partner WKYC-TV, discussing three Cleveland-area medical device companies: AxioMed Spine, CerviLenz and Neuros Medical.

[Read more of this report]


Preterm birth risk could be halved with CerviLenz, progesterone

CerviLenz is a simple, low-tech medical device that prompts a “why didn’t I think of that?” response from many obstetricians.Yet the device that quickly, accurately and inexpensively measures a pregnant woman’s cervix could help answer the $26 billion-a-year problem of preterm births in the United States.And CerviLenz, the Chagrin Falls, Ohio, company commercializing the device, [...]

[Read more of this report]


CerviLenz debuts inexpensive device to indicate preterm births

Obstetricians, nurse-midwives and labor and delivery nurses now have a powerful — and inexpensive — tool for assessing a woman’s risk of delivering a baby too early. CerviLenz.The disposable device made by CerviLenz Inc. — a Chagrin Falls, Ohio, startup — was introduced today at the American Academy of Obstetricians and Gynecologists annual meeting in [...]

[Read more of this report]


CerviLenz closes on $4 million Series A round to create preterm pregnancy detector

The company is developing a disposable device that measures the length of a woman’s cervix to help predict risks of preterm birth. It is potentially easier, less costly and just as accurate as the transvaginal ultrasound device used in only high-risk pregnancies. It could be in the market by 2010.

[Read more of this report]


Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics